Washington and Lee University Library
    • Login
    View Item 
    •   Digital Archive Home
    • W&L University Student Scholarship
    • W&L Shepherd Program for the Interdisciplinary Study of Poverty and Human Capability
    • View Item
    •   Digital Archive Home
    • W&L University Student Scholarship
    • W&L Shepherd Program for the Interdisciplinary Study of Poverty and Human Capability
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    The TRIPS Agreement and the Human Right to Essential Medicines

    Thumbnail
    View/Open
    Capstone paper (557.8Kb)
    Author
    McClellan, Melissa D.
    Subject
    Washington and Lee University, Shepherd Poverty Program
    Public health
    Agreement on Trade-Related Aspects of Intellectual Property Rights (1994)
    Compulsory licensing of patents
    Human rights
    Universal Declaration of Human Rights (United Nations. General Assembly)
    World Trade Organization
    World Health Organization
    Metadata
    Show full item record
    Description
    Melissa D. McClellan is a member of the Class of 2005 of Washington and Lee University School of Law.
     
    Capstone; [FULL-TEXT FREELY AVAILABLE ONLINE]
     
    Of course, patents are not the only, or even the primary, roadblocks to accessible medicine in developing nations. Over one-third of the world's population lacks access to the drugs on the WHO [World Health Organization] list of Essential Medicines, the great majority of which are not protected by patents in any country. As noted in a joint study by the WHO and WTO [World Trade Organization], "[t]he fact that billions of people lack access to essential drugs, most of which are not protected by patents,underscores the other problems contributing to inadequate access." The study identifies possible contributing factors to include insufficient distribution systems, poor financing, lack of capacity to import drugs, and the affordability of generic drugs for people in poor countries. . . . It does not follow, however, that because additional factors affect access to drugs the Members of the WTO should not attempt to make intellectual property laws socially responsible and responsive to human rights. . . . By shifting its focus from "public health" to individual human rights, the WTO could improve the clarity and effectiveness of the measures it has already taken to increase access to essential medicine. [From Conclusion]
     
    Melissa D. McClellan
     
    URI
    http://hdl.handle.net/11021/26034
    Collections
    • W&L Shepherd Program for the Interdisciplinary Study of Poverty and Human Capability

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of the Digital ArchiveCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV